Identifying risk factors for high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia

BACKGROUND: Whether monitoring of the methotrexate (MTX) concentrations after high-dose MTX (HD-MTX) infusion can predict toxicities is still controversial, especially when HD-MTX therapy is used in the treatment of children with acute lymphoblastic leukemia (ALL), which is different than the previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao, Sui, Zhongguo, Jing, Fanbo, Xu, Wen, Li, Xiangpeng, Guo, Qie, Sun, Shuhong, Bi, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615715/
https://www.ncbi.nlm.nih.gov/pubmed/31308758
http://dx.doi.org/10.2147/CMAR.S207959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615715/
https://www.ncbi.nlm.nih.gov/pubmed/31308758
http://dx.doi.org/10.2147/CMAR.S207959

Ejemplares similares